openPR Logo
Press release

Lower IVF Success Rates Widely Reported in Patients of African Origin

05-04-2011 08:53 AM CET | Health & Medicine

Press release from: Center for Human Reproduction

Lower IVF Success Rates Widely Reported in Patients of African

May 3, 2011 (New York, NY) – In vitro fertilization (IVF) pregnancy rates, also known as “IVF success rates” are related to specific genotypes and races/ethnicities, according to new research conducted by a New York City-based IVF center. It has long been known that IVF success rates (http://www.centerforhumanreprod.com/ivf-success-rates.html) differ amongst different races/ethnic groups. This new study suggests that predisposition to autoimmune disease (http://www.centerforhumanreprod.com/autoimmune_disease.html) may be the cause for these differences.

Despite general improvement in outcomes of fertility treatments, disparities between races/ethnicities have actually increased. Prevalence of infertility also differs in that African women experience infertility more frequently than Caucasians and Asians. Causes for these differences have remained largely unknown.

This new study, just published in the prestigious medical journal PLoS One (http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018781), was conducted by the Center for Human Reproduction (CHR) in New York, NY, and involved 339 Caucasian, Asian and African women. As previously widely reported in the medical literature, African patients demonstrated significantly lower IVF pregnancy rates, compared to Asian and Caucasian patients, even after controlling for age and BMI. African patients also demonstrated the highest rates of the recently described FMR1 (fragile X mental retardation) gene sub-genotype het-norm/low, which the same group of researchers previously reported to be statistically highly associated with autoimmunity. Asian women, with lowest prevalence of het-norm/low experienced the highest pregnancy rates after IVF.

“We have previously associated this specific FMR1 sub-genotype with an approximately 50% reduction in IVF pregnancy chances,” explains David Barad, MD, MS, one of the study’s senior authors, and Clinical Director of ART at CHR. “This new finding is in line with our previous studies on this specific FMR1 sub-genotype.”

“The association of FMR1 genotypes and risk for autoimmunity presents evidence that autoimmunity may be associated with lower pregnancy rates in IVF in general,” adds Norbert Gleicher, MD, the study’s second senior author, and Medical Director of CHR. “Autoimmunity may, thus, also be at least partially responsible for the racial/ethnic disparities in infertility prevalence and treatment outcomes.”

About Center for Human Reproduction
CHR (http://www.centerforhumanreprod.com) is a leading infertility center in New York City, with world-wide patient clientele, well recognized for its extensive clinical research program, which over the years contributed a number of major breakthrough to the IVF process. Drs. Gleicher and Barad are available for additional comments.

Communications Manager
21 E. 69th Street
New York, NY 10021
Phone: (212) 994-4400

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lower IVF Success Rates Widely Reported in Patients of African Origin here

News-ID: 173538 • Views:

More Releases from Center for Human Reproduction

IVF Success Rates Not Improved by Preimplantation Genetic Screening, According to CHR Research
IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates. In the late ‘90s,
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometrium
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1). In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles. The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Screening and Treatment
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype. In a paper

All 4 Releases


More Releases for IVF

IVF Devices and Consumables Market Size To Reach USD 7.73 Billion, Globally, By …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in awareness toward IVF, growth in demand for advanced IVF technologies, and surge in IVF success
IVF Services Market size is Generating Revenue of $25.6 Billion by 2026 | Fresh …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems and single mothers & the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and upsurge in disposable income
How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
Growth Dynamics on In Vitro Fertilization Market 2020-2026| Key Players: Monash …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
Growth Dynamics on In Vitro Fertilization Market 2020-2026| Key Players: Monash …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined